Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Hyperdibasic aminoaciduria, type 1 is characterized by increased renal clearance of lysine, ornithine and arginine, in the presence of normal concentrations of cystine. Heterozygous individuals are asymptomatic but homozygotes display intellectual deficit. To date, 25 heterozygotes and one homozygote have been reported.
Features include: Argininuria, Ornithinuria, Malabsorption, and Dibasicaminoaciduria and 2 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 1 | Malabsorption |
Brain and nerves | 1 | Intellectual disability |
No clinical trials have been registered for hyperdibasic aminoaciduria type 1.
1 publication has been identified in PubMed for hyperdibasic aminoaciduria type 1. Research spans Basic Science / Preclinical (100%).
Giroud-Gerbetant J (2025). [PMID: 39881295](https://pubmed.ncbi.nlm.nih.gov/39881295/). *Molecular medicine (Cambridge, Mass.)*. [Basic Science / Preclinical]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 6:44 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center